Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


The company has initiated and in process to start of production facilities as per PIC/S guidelines for oral and injectables dosage along with Lyophilization in the therapeutic segment of Oncology.

The company has developed certain new formulations under the segment of Antiretrovirals and Immunosuppressants.

The plant of the company and its associates are undergoing inspection for approval of PIC/S certification.

No Name No Name
   1 Antiretroviral   11 Antifungal
   2 Anti-TB   12 Antihelmintics
   3 Immunosuppressant   13 Antihistamines & Antitussive
   4 Antihypertensives / Cardiovascular   14 Antiemetics
   5 Antdiabetic   15 Antipsychotics
   6 Anticancer   16 Anti-inflammatory / Anti-rheumatic
   7 Antibacterials   17 Antispasmodics
   8 Antiulcerant   18 Corticosteroid
   9 Antiallergics   19 Haemostatics
  10 Antidepressant   20

Dietary supplement/
Nutritional Supplement
Mycophenolate Mofetil
Strength: 250mg, 500 mg
Dosage: Tablets
Indication: For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate mofetil should be used concomitantly with cyclosporine and corticosteroids.
Strength: 0.5 mg, 1.0 mg, 5.0 mg
Dosage: Capsule
Indication: For use after allogenic organ transplant to reduce the activity of the patient's immune system and It has also been used in a topical preparation in the treatment of severe atopic dermatitis.It is used for the prophylaxis of organ rejection in patients of organ transplant.
Leflunomide Tablets
Strength: 10 mg & 20 mg
Dosage: Tablet
Sirolimus Tablets
Strength: 0.5 mg, 2.0 mg
Dosage: Tablet
Everolimus Tablets
Strength: 0.25 mg, 0.50 mg , 0.75 mg & 1.0 mg
Dosage: Tablet
© 2009 Lok Beta Pvt. Ltd. All rights reserved.
Sitemap   |   Privacy Policy   |   Credits